Hyperbranched Biorefinery Molecule‐Regulated Switchable Adhesion and Noninvasive Healing

Why It Matters

The technology offers a high‑performance, bio‑based adhesive that can be switched off for non‑invasive wound repair, opening new pathways for safe medical devices and reducing reliance on petrochemical adhesives.

Key Takeaways

• Hyperbranched polysaccharide sourced from microbial fermentation
• Dynamic disulfide bonds enable energy dissipation and stress redistribution
• Adhesion switches from 296 N/m to 17 N/m with high stability
• Achieves 94.8% wound closure in 10 days versus 76.1% control

Pulse Analysis

Switchable adhesives have long promised breakthroughs in flexible electronics, soft robotics, and especially tissue repair, yet most existing solutions rely on synthetic polymers that lack biocompatibility and sustainability. By turning to biorefinery‑derived hyperbranched polysaccharides, researchers tap into a renewable feedstock that sidesteps the long production cycles and batch variability typical of biomass‑based materials. The microbial fermentation route yields a uniform, nanoconfined architecture that serves as a scaffold for dense dynamic disulfide linkages, marrying ecological responsibility with cutting‑edge performance.

The core innovation lies in the nanoconfinement effect, which concentrates dynamic bonds at the adhesive interface. When stress is applied, these bonds break and reform, dissipating energy and redistributing load across the material. This mechanism delivers an impressive adhesion strength while allowing the bond to be toggled off on demand, demonstrated by a switching span from 296 N/m down to 17 N/m. Such a wide, reversible range is rare for bio‑based adhesives and positions the material for applications where temporary yet robust attachment is critical, such as implantable sensors or detachable wound dressings.

In pre‑clinical wound‑healing studies, the adhesive closed 94.8% of wounds after ten days, markedly higher than the 76.1% achieved by conventional dressings. This performance, combined with its non‑invasive removal, suggests a compelling value proposition for hospitals seeking safer, greener wound‑care solutions. The technology also aligns with growing regulatory and consumer demand for sustainable medical products, potentially reshaping the adhesive market and spurring further investment in biorefinery‑derived polymers. Future work will likely explore scaling fermentation processes and integrating the adhesive with smart medical devices.